A new report on medicines shortages experienced in European healthcare systems published on Monday (17 November) by the European Association of Hospital Pharmacists (EAHP) reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines in the EU.
The EAHP surveyed the experiences of over 600 hospital pharmacists in 36 European countries. Its report presents a gloomy picture of how medicines shortages are affecting the treatment of patients across the continent.
Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
The nanoparticles—dubbed nanoflares—attach themselves to individual cancer cells in a blood sample and then glow, allowing cancerous cells to be detected and sorted with the help of a laser. Since different types of cancer cells—some of which are far more lethal than others—can be detected and collected using the technique, and since those cells can then be cultured in a dish, the nanoparticles may also make it easier to test potential treatments before giving them to patients.
Cities around the globe, whether rich or poor, are in the midst of a technology experiment. Urban planners are pulling data from inexpensive sensors mounted on traffic lights and park benches, and from mobile apps on citizens’ smartphones, to analyze how their cities really operate. They hope the data will reveal how to run their cities better and improve urban life. City leaders and technology experts say that managing the growing challenges of cities well and affordably will be close to impossible without smart technology.
On October 6, a Boeing 747 modified for testing jet engines taxied along a concrete runway on the edge of the Mojave Desert and took off with a brand new engine strapped to its left wing. Although the engine’s maiden flight was short, it made aviation history.
Born from the ashes of Nokia’s ‘Wellness’ initiative — part of Nokia Research Center, which, by some estimates, helped make the once mobile giant the third largest R&D spender in Europe as recently as 2011 — is Wellmo, another Finnish startup operating in the health and fitness space.
Las compañías estadounidenses, que han encabezado la inversión occidental en el gigante asiático los pasados 35 años, van a reducir sus expectativas y planes de negocio ante la ralentización del crecimiento, la elevada competencia y el incremento de supervisión reguladora.
En declaraciones recogidas por el diario 'South China Morning Post', John Frisbie, presidente del Consejo Empresarial Estados Unidos-China, afirma que “existe mucha incertidumbre política entre la comunidad empresarial”.
El BOG publica hoy las bases reguladoras y convocatoria de 2014 de las subvenciones a los municipios de menos de 7.000 habitantes del Territorio Histórico de Gipuzkoa, destinadas a financiar los gastos derivados de la adaptación de sus instrumentos urbanísticos de planeamiento municipal de ordenación general a la Ley 2/2006, de 30 de junio, de Suelo y Urbanismo.
El nexo adjunto permite acceder al texto de la orden…:
Few biotech startups have burst onto the scene like Juno Therapeutics. The Seattle company secured $310 million in private financing in less than a year, budding out of cancer immunotherapy work at three of the nation’s premier cancer centers in New York and Seattle.
With that type of momentum, it was only a matter of time until Juno took itself public. And today Juno is showing it’s ready to take the plunge.
Robots have long been cast as human helpers in movies and the public imagination. Now delivery robots are becoming a reality—so long as the robots stay indoors.
The Aloft Hotel in Palo Alto, CA, is now employing a robot from Silicon Valley startup Savioke to deliver small items from the front desk to rooms. By next year, Savioke expects more of its robots, called SaviOne, to roam more hotels in the Aloft hotel’s chain as well as other hotels, says Steve Cousins, the CEO and founder of Savioke.
Esta es la pregunta a la cual pretende responder la sesión DREAMWORKS en el ámbito de la Cooperación internacional y la Ayuda Humanitaria que se desarrollará el día 27 de noviembre de 2014, a partir de las 9 de la mañana, en el Palacio de Otalora de Aretxabaleta.
Así, esta sesión DREAMWORKS permitirá identificar ámbitos de necesidades humanas y sociales que propicien el desarrollo de nuevos productos y servicios, así como identificar nuevos canales de acceso a mercados no convencionales.
A modo de ilustración, Paul Cabrera, Responsable Técnico de Construcción y Non Food Items del Departamento de Logística de Médicos sin Fronteras – MSF, presentará los retos que presentan las intervenciones de asistencia humanitaria en ámbitos tales como:
